Literature DB >> 6762248

Influence of immune status of host on immunogenicity of tumors induced with two doses of methylcholanthrene.

E M Lawler, R T Prehn.   

Abstract

Previous studies by Prehn demonstrated a direct correlation between the dose of carcinogen used for tumor induction and the immunogenicity of the resulting tumors. The purpose of the present study was to determine the role of the host's immune response and the influence of the carcinogen on immune function in this relationship. For that reason, a comparison was made of the immunogenicities of tumors induced with two doses of carcinogen in immunologically normal mice and in mice immunodepressed by adult thymectomy and irradiation. If the direct relationship between dose and immunogenicity demonstrated in normal mice was due to the degree of immunosuppression produced by the carcinogen, this correlation should not be apparent in mice already immunosuppressed. Although there was some increase in the immunogenicity of tumors induced in the immunosuppressed mice, the same relationship between carcinogen dose and immunogenicity was observed in both groups of mice. These results indicate that the degree of immunogenicity of tumors induced with both high and low doses of carcinogen was influenced by immunoselection, but in addition another, non-immunologic factor was significant in the relationship between carcinogen dose and immunogenicity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6762248     DOI: 10.1007/bf00205388

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  13 in total

1.  ANTIGENIC SPECIFICITY OF BENZO(A)PYRENE-INDUCED SARCOMAS.

Authors:  A GLOBERSON; M FELDMAN
Journal:  J Natl Cancer Inst       Date:  1964-06       Impact factor: 13.506

2.  FUNCTION OF DEPRESSED IMMUNOLOGIC REACTIVITY DURING CARCINOGENESIS.

Authors:  R T PREHN
Journal:  J Natl Cancer Inst       Date:  1963-10       Impact factor: 13.506

3.  Radiosensitive and radioresistant phases in the antibody response.

Authors:  F J DIXON; D W TALMAGE; P H MAURER
Journal:  J Immunol       Date:  1952-06       Impact factor: 5.422

4.  Antigenicity of clones of mouse prostate cells transformed in vitro.

Authors:  M J Embleton; C Heidelberger
Journal:  Int J Cancer       Date:  1972-01-15       Impact factor: 7.396

5.  Effect of host immunity on the antigenic strength of primary tumors.

Authors:  G L Bartlett
Journal:  J Natl Cancer Inst       Date:  1972-08       Impact factor: 13.506

6.  Antigenicity of cells derived from mouse prostate cells after malignant transformation in vitro by carcinogenic hydrocarbons.

Authors:  S Mondal; P T Iype; L M Griesbach; C Heidelberger
Journal:  Cancer Res       Date:  1970-06       Impact factor: 12.701

7.  The relationship of immunology to carcinogenesis.

Authors:  R T Prehn
Journal:  Ann N Y Acad Sci       Date:  1969-10-14       Impact factor: 5.691

8.  Immunodepression and malignancy.

Authors:  O Stutman
Journal:  Adv Cancer Res       Date:  1975       Impact factor: 6.242

9.  Relationship of tumor immunogenicity to concentration of the oncogen.

Authors:  R T Prehn
Journal:  J Natl Cancer Inst       Date:  1975-07       Impact factor: 13.506

10.  The effect of thymectomy and of the dose of 3-methylcholanthrene on the induction and antigenic properties of sarcomas in C56Bl mice.

Authors:  S Johnson
Journal:  Br J Cancer       Date:  1968-03       Impact factor: 7.640

View more
  4 in total

Review 1.  Tumor immunogenicity: how far can it be pushed?

Authors:  R T Prehn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

Review 2.  An immune reaction may be necessary for cancer development.

Authors:  Richmond T Prehn
Journal:  Theor Biol Med Model       Date:  2006-02-03       Impact factor: 2.432

3.  Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.

Authors:  Christine V Ichim
Journal:  J Transl Med       Date:  2005-02-08       Impact factor: 5.531

4.  On the nature of cancer and why anticancer vaccines don't work.

Authors:  Richmond T Prehn
Journal:  Cancer Cell Int       Date:  2005-08-01       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.